Skip to main content
. 2018 Aug 15;48(7):761–767. doi: 10.1111/apt.14939

Table 2.

Tolerable and intolerable adverse events on AZA, MP and TG therapy

AZA or MP (N = 49) TG (N = 52)
Tolerable Intolerable Tolerable Intolerable
Patients with an AE 6 38 4 7
Nausea and vomiting 6 20 1
Headache 2 1 2
Fatigue 2 7 1
Myalgia/arthralgia 1 6 3
Itch 1 1
Rash 1 1
Abdominal pain 1 3 1
Fever 1 5 1
Malaise 4 1
Alopecia 2
Hot flushes 1
Diarrhoea 1
Myelotoxicity 2 4 1

AE: adverse event; AZA: azathioprine; MP: mercaptopurine; TG: tioguanine.

Patients could report multiple side effects.